6939 Stock Overview
A contract research organization, provides biological testing services in Taiwan. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
TFBS Bioscience Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$29.50 |
52 Week High | NT$47.80 |
52 Week Low | NT$28.20 |
Beta | 0 |
1 Month Change | -22.37% |
3 Month Change | -21.12% |
1 Year Change | -36.01% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -56.30% |
Recent News & Updates
Recent updates
Shareholder Returns
6939 | TW Life Sciences | TW Market | |
---|---|---|---|
7D | -18.8% | 1.9% | -2.1% |
1Y | -36.0% | -25.1% | 25.6% |
Return vs Industry: 6939 underperformed the TW Life Sciences industry which returned -25.1% over the past year.
Return vs Market: 6939 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
6939 volatility | |
---|---|
6939 Average Weekly Movement | 4.0% |
Life Sciences Industry Average Movement | 4.2% |
Market Average Movement | 4.4% |
10% most volatile stocks in TW Market | 7.8% |
10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6939 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6939's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | Tatung Yuan | www.tfbsbio.com |
TFBS Bioscience Inc., a contract research organization, provides biological testing services in Taiwan. It offers viral vector manufacturing services for cell and gene therapy products; and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products. The company was incorporated in 2016 and is headquartered in New Taipei City, Taiwan.
TFBS Bioscience Inc. Fundamentals Summary
6939 fundamental statistics | |
---|---|
Market cap | NT$1.03b |
Earnings (TTM) | NT$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 6939 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6939 income statement (TTM) | |
---|---|
Revenue | NT$0 |
Cost of Revenue | NT$0 |
Gross Profit | NT$0 |
Other Expenses | NT$0 |
Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 6939 perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 11:19 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | N/A |
Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
TFBS Bioscience Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|